Sampo plc
Sampo plc’s share buybacks 12 January 2026
Sampo plc’s share buybacks 12 January 2026
Sampo plc, stock exchange release, 13 January 2026 at 8:30 am EET
Sampo plc’s share buybacks 12 January 2026
On 12 January 2026, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:
| Sampo plc’s share buybacks | Aggregated daily volume (in number of shares) | Daily weighted average price of the purchased shares* | Market (MIC Code) |
| 4,002 | 9.92 | AQEU | |
| 163,204 | 9.92 | CEUX | |
| 38,711 | 9.92 | TQEX | |
| 175,087 | 9.92 | XHEL | |
| TOTAL | 381,004 | 9.92 |
* rounded to two decimals
On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November 2025, is based on the authorisation granted by Sampo's Annual General Meeting on 23 April 2025.
After the disclosed transactions, the company owns in total 10,900,775 Sampo A shares representing 0.41 per cent of the total number of shares in Sampo plc.
Details of each transaction are included as an appendix of this announcement.
On behalf of Sampo plc,
Morgan Stanley
For further information, please contact:
Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030
Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
Nasdaq Copenhagen
London Stock Exchange
FIN-FSA
The principal media
www.sampo.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Karolinska Development AB (publ)13.1.2026 08:30:00 CET | Press release
The subscription period in Karolinska Development AB (publ)’s rights issue begins today
ING Group13.1.2026 08:06:33 CET | Press release
Progress on share buyback programme
Basilea Pharmaceutica AG, Allschwil13.1.2026 07:15:00 CET | Press release
Basilea joins INCATE to support antifungal innovation
Kuros Biosciences AG13.1.2026 07:00:00 CET | Press release
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
Sika AG13.1.2026 05:00:00 CET | Press release
SIKA REPORTS PRELIMINARY 2025 SALES OF CHF 11.2 BILLION
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom